# A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy

> **NCT04803786** · — · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 110 (actual)

## Conditions studied

- Narcolepsy

## Interventions

- **DRUG:** Transition from Xyrem to Xywav

## Key facts

- **NCT ID:** NCT04803786
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-09
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04803786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04803786, "A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04803786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*